Introduction
============

Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome (OMIM 146255) is a hereditary disease with autosomal dominant transmission. This syndrome was first described in 1992 ([@B1]) and was subsequently named HDR syndrome by Hasegawa et al., who detected a deletion on chromosome 10p15 ([@B2]). Esch et al. went on to identify the causal genetic abnormality of this disease within this region: mutations in the *GATA3* gene ([@B3]).

GATA3 is mainly expressed in the parathyroid, inner ear, and kidney during embryonic development. In the embryonic kidney, GATA3 is strongly expressed in the collecting ducts and weakly expressed in glomerular mesangial cells ([@B4], [@B5]). In the normal adult kidney, GATA3 expression is rarely found, but there are a few positive cells in the mesangial area ([@B6]). Experimental findings show that GATA3 is indispensable for kidney development, especially for ureteric bud formation ([@B7]), and is regulated by Pax2 and Pax8 ([@B5]).

The common renal phenotype of HDR syndrome is a structural anomaly introduced during development. A recent review of previous cases showed that renal dysplasia, hypoplasia, or aplasia was most common (41% of HDR patients), and a cyst or pelvicalyceal deformity was observed in 11% of patients ([@B8]). Of note, this mutation has variable expressivity, even for the same mutation in the same family ([@B8], [@B9]). Regarding the glomerular phenotype, there have been only a few reports on glomerular lesions in cases of HDR syndrome. In a 4-year-old patient who presented nephrotic range proteinuria and moderate hematuria, unusual proliferative glomerulonephritis was observed on light microscopy, but immunofluorescence and electron microscopy findings were not available ([@B10]). Other reports on adult biopsy cases with HDR syndrome complicated with vesicoureteral reflux revealed that 50% of glomeruli had focal segmental glomeruloscrelosis lesions ([@B8]). However, there have been no report of adult HDR patients with unusual proliferative glomerulonephritis.

We herein report an adult case of HDR syndrome with a novel *GATA3* mutation and unusual proliferative glomerulonephritis and discuss the possible mechanisms underlying the development of glomerular lesions in HDR patients.

Case Report
===========

A 52-year-old Japanese man was admitted to our hospital with moderate proteinuria and renal dysfunction. Proteinuria was initially detected at 18 years old. At 40 years old, he was diagnosed with sensorineural deafness. At 47 years old, he was diagnosed with hypoparathyroidism and alfacalcidol was initially administered. At the same time, he was diagnosed with viral hepatitis B infection based on positive blood tests for hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV)-DNA. Regarding the other risk factors for the progression of kidney diseases, he was diagnosed with mild hypertension and moderate hyperlipidemia several years prior to the admission, but these were appropriately controlled thereafter. His sister and nephew had deafness and renal disease, presenting mild to moderate renal insufficiency and mild proteinuria, and his son and father had deafness ([Fig. 1](#g001){ref-type="fig"}).

A laboratory examination on admission showed moderate renal insufficiency, and a urinalysis revealed moderate proteinuria and mild elevation of N-acetyl-β-D-glucosaminidase and β2-microglobulin; however, hematuria was not apparent. Serological findings showed no increase in autoantibodies, but serum samples tested positive for HBsAg and HBV-DNA ([Table](#t001){ref-type="table"}). On abdominal echography, the size of both kidneys was preserved, and some renal cysts were observed, but urinary tract deformity was not present ([Fig. 2](#g002){ref-type="fig"}).

![Family tree. The proband is indicated by an arrow. The presence of the hypoparathyroidism, sensorineural deafness, and renal disease triad is indicated by colors in each quartered area.](1349-7235-56-1393-g001){#g001}

###### 

Laboratory Data Obtained at Admission.

  ----------------- ------------ ----------------- -------------------- -------- -------------------
  Hematology                                       Serology                      
  WBC               7,100        /μL               IgG                  1,551    mg/dL
  Hb                13.9         g/dL              IgA                  375      mg/dL
  Platelet          22.9×10^4^   /μL               IgM                  131      mg/dL
                                                   complement3          67.9     mg/dL
  Biochemistry                                     complement4          13.4     mg/dL
  Total protein     6.8          g/dL              CH50                 35.9     U/mL
  Albumin           3.6          g/dL              C-reactive protein   0.21     mg/dL
  Urea nitrogen     30.2         mg/dL             ANA                  \<×40    
  Creatinine        1.86         mg/dL             HBs-Ag               60,618   IU/mL
  eGFR              31.7         mL/min/1.73m^2^   HBV-DNA              8.6      log copies/mL
  Sodium            137          mEq/L             HCV-Ab               \-       
  Potassium         5.1          mEq/L             Cryoglobulin         \-       
  Chloride          105          mEq/L                                           
  Calcium           9.2          mg/dL             Urinalysis                    
  Phosphorus        4.1          mg/dL             sp gr                1.014    
  Total bilirubin   0.43         mg/dL             pH                   8.5      
  AST               27           IU/L              Protein              1.52     g/gCreatinine
  ALT               33           IU/L              Glucose              \-       
  LDH               210          IU/L              RBC sediment         1-4      /high power field
  ALP               202          IU/L              beta-2-MG            767      µg/gCreatinine
  γ-GTP             20           IU/L              NAG                  22       U/gCreatinine
  Hemoglobin A1c    5.4          \%                BJP                  \-       
  ----------------- ------------ ----------------- -------------------- -------- -------------------

eGFR: estimated glomerular filtration rate, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γ-GTP: gamma-glutamyl transpeptidase, CH50: 50% hemolytic unit of complement, ANA: antinuclear antibody, HBs-Ag: hepatitis B surface antigen, HBV-DNA: hepatitis B virus-DNA, HCV-Ab: hepatitis C virus antibody, sp gr: specific gravity, RBC sediment: red blood cell sediment, beta-2-MG: beta-2-microglobulin, NAG: N-acetyl-beta-D-glucosaminidase, BJP: Bence Jones protein

![Echography of both kidneys. Some renal cysts were observed, but no atrophy or anomalies were present in either kidney.](1349-7235-56-1393-g002){#g002}

To determine the pathogenesis of proteinuria in this patient, we performed a kidney biopsy. On light microscopy, 25% of glomeruli showed global sclerosis, and the major lesion in the rest of the glomeruli was segmental mesangial proliferation with a partial double contour of the glomerular basement membrane, indicating unusual proliferative glomerulonephritis ([Fig. 3a and b](#g003){ref-type="fig"}). The other lesions were focal segmental sclerosis (5% of glomeruli), and 1 glomerulus showed fibro-cellular crescent formation. Regarding tubulo-interstitial lesions, mild to moderate fibrosis and tubular atrophy were found ([Fig. 3b](#g003){ref-type="fig"}). The patient had had hypertension and hyperlipidemia, but there was no apparent arterio-arteriolosclerosis.

Immunofluorescence examinations showed neither immunoglobulin nor complement deposition except for faint IgM staining along the glomerular basement membrane ([Fig. 3c](#g003){ref-type="fig"}). On electron microscopy, ill-demarcated and low-electron-density deposits were localized at the subendothelial area and within the glomerular basement membrane ([Fig. 3e](#g003){ref-type="fig"}). Mesangial interposition and foot process effacement were also observed ([Fig. 3e](#g003){ref-type="fig"}). Given these results, we diagnosed his kidney disease as unusual proliferative glomerulonephritis type I. To determine whether or not the hepatitis B virus played a role in the glomerular lesion development, we performed immunostaining for HBsAg and obtained negative staining results ([Fig. 3d](#g003){ref-type="fig"}).

![Kidney biopsy findings. a) Light microscopy findings of periodic acid-methenamine-silver staining (magnification×400). Glomerular basement membrane duplication (arrowhead) and endocapillary proliferation (small square) were observed. b) Light microscopy findings of periodic acid-Schiff staining (magnification×100). Segmental mesangial proliferation (small square) and moderate interstitial injury (arrowheads) were observed. c) The findings of the immunofluorescence staining. IgG (-), IgM (+). d) The findings of immunohistochemistry for hepatitis B surface antigen (HBsAg) (magnification×400), which was negative in the glomeruli. e) The electron microscopy findings of the glomerulus (magnification×2,500 and ×15,000). A magnified view of the outlined region in the lower-magnification picture is shown as a separate picture. Ill-demarcated and low-electron-density deposits were observed within the glomerular basement membrane. Mesangial interposition and foot process effacement were also present.](1349-7235-56-1393-g003){#g003}

We strongly suspected that the patient had HDR syndrome and performed a genetic analysis of the causal gene (i.e. *GATA3*) for confirmation. We detected a novel heterozygous p.C288W (TGC\>TGG) missense mutation in *GATA3*at the codon encoding a cysteine residue that forms ZnF1. Accordingly, based on the genetic analysis and the clinical parameters, we diagnosed the patient with HDR syndrome. These findings together with the lack of notable arterio-arteriolo sclerosis on light microscopy suggest that the glomerular lesion, which might have been introduced by a *GATA3* mutation, eventually led to renal insufficiency. His renal function gradually deteriorated, and maintenance hemodialysis was initiated two years after the kidney biopsy.

Discussion
==========

We herein describe a patient with HDR syndrome and hypoparathyroidism, sensorineural deafness, and glomerulonephritis. We also identified an unusual proliferation based on the renal histology. Genetic tests showed a novel mutation in the*GATA3* gene.

Human *GATA3* encodes 444 amino acids and contains 2 transactivating domains (TA1 and TA2) and 2 zinc finger DNA-binding domains (ZnF1 and ZnF2). Experimental findings have shown that ZnF2 is the actual DNA binding site of GATA3, and ZnF1 stabilizes this binding and interacts with other zinc finger proteins, such as Friends of GATA (FOG) ([@B11]-[@B14]). The mutation in our patient was found at a ZnF1-encoding cysteine residue, where zinc directly binds. Ali et al. analyzed 38 *GATA3* mutations and classified HDR syndrome patients into 3 groups according to alterations in the binding between DNA and the mutant *GATA3* ([@B13]). One group is characterized by a complete loss of DNA binding, which is mainly caused by a lack of ZnF2, where DNA directly binds. The second group exhibits a decrease in DNA-binding affinity; this mainly involves mutations in ZnF1, which strengthen the binding between DNA and GATA3. The last group is characterized by a loss of transcription owing to a conformational change in GATA3, despite normal DNA binding and normal affinity. Under this classification system, our patient fell into the second group.

Even though the *GATA3* mutation in our patient caused HDR syndrome, it is still unclear whether or not this mutation was related to the membranoproliferative glomerulonephritis-like lesion observed in the renal histology. Many previous reports have examined the *GATA3* expression in the developing kidney; however, very few studies have examined its expression in the adult kidney. Chan et al. have shown that GATA3 is weakly expressed in lupus nephritis kidneys ([@B15]). Sun et al. analyzed the *GATA3* expression in allograft kidneys and detected intraglomerular *GATA3* expression in 76.5% of the antibody-mediated rejection group, 93.5% of the T-cell-mediated rejection group, and 27.3% of recipients with a normal graft function. In their report, the *GATA3* expression was scattered in the glomeruli and located mainly in the mesangial area ([@B6]).

Regarding the relationship between *GATA3* mutations and the development of glomerular lesions in our patient, one possible mechanism is the imbalance of immunoreaction through the two subsets of T-helper cells: Th1 and Th2. GATA3 is indispensable for the differentiation of naïve T cells into Th2 cells, subsequently upregulating Th2 cytokines like IL-4 ([@B16]). IL-4 suppresses the differentiation of naïve T cells into Th1 cells, which further shifts the Th1/Th2 pendulum toward the Th2-related immunoresponse. Holdsworth et al. found that Th1/Th2 predominance affected the patterns and severity of glomerulonephritis and that membranoproliferative glomerulonephritis was an entity introduced by a Th1-dominant immunoresponse ([@B17]). Despite the lack of direct evidence, these recent observations suggest that a loss of the function of GATA3 due to a genome mutation might lead to a Th1-dominant immunoresponse, eventually contributing to the progression of membranoproloferative lesions observed in the present case.

In our patient, a serological examination revealed high levels of HBsAg and HBV-DNA with normal liver enzyme values, indicating that he is an HBV carrier. The common morphological forms of HBV-associated glomerulonephritis are membranous nephropathy, mesangial proliferative glomerulonephritis, and membranoproliferative glomerulonephritis ([@B18]), which was found in our patient. HBV-associated membranoproliferative glomerulonephritis is usually characterized by the deposition of circulating antigen-antibody complexes in the mesangial and subendothelial spaces, which are positive for IgG and C3 ([@B18]). However, immunostaining results for IgG and HBsAg were negative in the glomeruli, suggesting that HBV antigens and the immune responses against them might not have contributed to the glomerular lesion development in our patient. In addition, electron microscopy showed that the electron-dense deposits did not exhibit a fibrillary or band-like structure, which excludes the possibility that the glomerular lesions were caused by renal amyloidosis or Randall-type monoclonal immunoglobulin deposition diseases. These findings, together with those from a previous report on a similar membranoproliferative glomerulonephritis-like glomerular lesion in a 4-year-old HDR syndrome patient ([@B10]), suggest that the renal lesion in our patient might have been caused by his HDR syndrome.

In summary, we presented an HDR patient with a novel missense mutation in *GATA3* affecting the zinc finger 1 domain. We also described the likely clinical impact of this disease-namely the development of unusual proliferation in the renal histology. Additional histological analyses of the kidneys of HDR syndrome patients are warranted, and these analyses may clarify the role of GATA3 not only in the developing kidney but also in the adult kidney, especially in the glomerulus.
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